Morgan Stanley Zoetis Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Zoetis Inc. stock. As of the latest transaction made, Morgan Stanley holds 12,746,043 shares of ZTS stock, worth $2.15 Billion. This represents 0.15% of its overall portfolio holdings.

Number of Shares

12,746,043

Previous 11,844,667 7.61%

Holding current value

$2.15 Billion

Previous $1.93 Billion 8.75%

% of portfolio

0.15%

Previous 0.14%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$156.48 - $175.67 $141 Million - $158 Million	901,376 Added 7.61%	12,746,043 $2.1 Billion
Q4 2024 Feb 14, 2025	SELL	$162.24 - $194.42 $32 Million - $38.4 Million	-197,357 Reduced 1.64%	11,844,667 $1.93 Billion
Q3 2024 May 14, 2025	SELL	$172.58 - $196.48 $230 Million - $262 Million	-1,332,989 Reduced 9.97%	12,042,024 $2.35 Billion
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $230 Million - $262 Million	-1,332,989 Reduced 9.97%	12,042,024 $2.35 Billion
Q2 2024 May 14, 2025	BUY	$145.54 - $178.83 $223 Million - $274 Million	1,530,346 Added 12.92%	13,375,013 $2.32 Billion
Q2 2024 Oct 17, 2024	BUY	$145.54 - $178.83 $71.5 Million - $87.9 Million	491,542 Added 3.82%	13,375,013 $2.32 Billion
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $71.5 Million - $87.9 Million	491,542 Added 3.82%	13,375,013 $2.32 Billion
Q1 2024 Oct 17, 2024	SELL	$165.67 - $199.94 $81.4 Million - $98.3 Million	-491,542 Reduced 3.68%	12,883,471 $2.18 Billion
Q1 2024 Aug 16, 2024	BUY	$165.67 - $199.94 $93.6 Million - $113 Million	564,723 Added 4.58%	12,883,471 $2.18 Billion
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $93.6 Million - $113 Million	564,723 Added 4.58%	12,883,471 $2.18 Billion
Q4 2023 Aug 16, 2024	SELL	$151.44 - $200.09 $160 Million - $211 Million	-1,056,265 Reduced 7.9%	12,318,748 $2.43 Billion
Q4 2023 Feb 13, 2024	BUY	$151.44 - $200.09 $7.47 Million - $9.86 Million	49,294 Added 0.4%	12,318,748 $2.43 Billion
Q3 2023 Nov 15, 2023	SELL	$167.14 - $192.77 $39.6 Million - $45.7 Million	-236,941 Reduced 1.89%	12,269,454 $2.13 Billion
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $156 Million - $181 Million	969,797 Added 8.41%	12,506,395 $2.15 Billion
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $96.6 Million - $116 Million	663,894 Added 6.11%	11,536,598 $1.92 Billion
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $367 Million - $440 Million	2,796,694 Added 34.63%	10,872,704 $1.59 Billion
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $59.3 Million - $72.9 Million	399,592 Added 5.21%	8,076,010 $1.2 Billion
Q2 2022 Oct 27, 2022	BUY	$155.97 - $200.09 $249 Million - $320 Million	1,599,481 Added 26.32%	7,676,418 $1.32 Billion
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $249 Million - $320 Million	1,599,481 Added 26.32%	7,676,418 $1.32 Billion
Q1 2022 Oct 27, 2022	SELL	$181.39 - $234.03 $290 Million - $374 Million	-1,599,481 Reduced 20.84%	6,076,937 $1.15 Billion
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $77.4 Million - $99.9 Million	426,756 Added 7.55%	6,076,937 $1.15 Billion
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $119 Million - $151 Million	-613,267 Reduced 9.79%	5,650,181 $1.38 Billion
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $1.19 Billion - $1.31 Billion	6,263,448 New	6,263,448 $1.22 Billion

Others Institutions Holding ZTS

# of Institutions

2,112

Shares Held

421M

Call Options Held

1.98M

Put Options Held

1.03M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account